Pyrazolo[4,3-C] quinoline derivatives for inhibition of β-glucuronidase
申请人:Kaohsiung Medical University
公开号:US11052072B2
公开(公告)日:2021-07-06
The present invention provides novel pyrazolo[4,3-c]quinoline derivatives exhibiting specifically inhibition activity to microbiota β-glucuronidase, whereby providing potent activities to prevent chemotherapy-induced diarrhea (CID) of cancers. Therefore, the compounds of the present invention can be used as (1) chemotherapy-adjuvant to prevent chemotherapy-induced diarrhea (CID) and enhance chemotherapeutic efficiency of cancers; (2) health-food supplement to prevent the carcinogens induced colon carcinoma.
COMPOSES HETEROCYCLIQUES SUBSTITUES, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
申请人:SANOFI
公开号:EP0807111A1
公开(公告)日:1997-11-19
US9617272B2
申请人:——
公开号:US9617272B2
公开(公告)日:2017-04-11
US9981973B2
申请人:——
公开号:US9981973B2
公开(公告)日:2018-05-29
PRODRUGS OF OPIOIDS AND USES THEREOF
申请人:Franklin Richard
公开号:US20110190267A1
公开(公告)日:2011-08-04
The present invention concerns prodrugs of opioid analgesics and pharmaceutical compositions containing such prodrugs. Methods for providing more consistent pain relief by increasing the bioavailability of the opioid analgesic with the aforementioned prodrugs are provided. The invention also provides for decreasing the adverse GI side effects of opioid analgesics.